EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.
Employees: 1-10
News 72
Show more
Mentions in press and media 1
Date | Title | Description |
14.10.2015 | Luxendo Closes €6M Series A Financing | Luxendo, a startup launched by the European Molecular Biology Laboratory (EMBL) and its technology transfer arm EMBLEM Technology Transfer (EMBLEM) in Heidelberg, Germany, closed a €6M Series A financing. The round was co-led by EMBL Ventur... |